Tags

Type your tag names separated by a space and hit enter

Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis.
Euro Surveill. 2013 Feb 14; 18(7):2.ES

Abstract

We present estimates of influenza vaccine effectiveness (VE) in Navarre, Spain, in the early 2012/13 season, which was dominated by influenza B. In a population-based cohort using electronic records from physicians, the adjusted VE in preventing influenzalike illness was 32% (95% confidence interval (CI): 15 to 46). In a nested test-negative case-control analysis the adjusted VE in preventing laboratory-confirmed influenza was 86% (95% CI: 45 to 96). These results suggest a high protective effect of the vaccine.

Authors+Show Affiliations

Instituto de Salud Publica de Navarra-Public Health Institute of Navarre, Pamplona, Spain. jcastilc@navarra.esNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

23449182

Citation

Castilla, J, et al. "Early Estimates of Influenza Vaccine Effectiveness in Navarre, Spain: 2012/13 Mid-season Analysis." Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, vol. 18, no. 7, 2013, p. 2.
Castilla J, Martinez-Baz I, Martinez-Artola V, et al. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis. Euro Surveill. 2013;18(7):2.
Castilla, J., Martinez-Baz, I., Martinez-Artola, V., Fernandez-Alonso, M., Reina, G., Guevara, M., Garcia Cenoz, M., Elia, F., Alvarez, N., Barricarte, A., & Ezpeleta, C. (2013). Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis. Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 18(7), 2.
Castilla J, et al. Early Estimates of Influenza Vaccine Effectiveness in Navarre, Spain: 2012/13 Mid-season Analysis. Euro Surveill. 2013 Feb 14;18(7):2. PubMed PMID: 23449182.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis. AU - Castilla,J, AU - Martinez-Baz,I, AU - Martinez-Artola,V, AU - Fernandez-Alonso,M, AU - Reina,G, AU - Guevara,M, AU - Garcia Cenoz,M, AU - Elia,F, AU - Alvarez,N, AU - Barricarte,A, AU - Ezpeleta,C, Y1 - 2013/02/14/ PY - 2013/3/2/entrez PY - 2013/3/2/pubmed PY - 2013/4/25/medline SP - 2 EP - 2 JF - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin JO - Euro Surveill. VL - 18 IS - 7 N2 - We present estimates of influenza vaccine effectiveness (VE) in Navarre, Spain, in the early 2012/13 season, which was dominated by influenza B. In a population-based cohort using electronic records from physicians, the adjusted VE in preventing influenzalike illness was 32% (95% confidence interval (CI): 15 to 46). In a nested test-negative case-control analysis the adjusted VE in preventing laboratory-confirmed influenza was 86% (95% CI: 45 to 96). These results suggest a high protective effect of the vaccine. SN - 1560-7917 UR - https://www.unboundmedicine.com/medline/citation/23449182/Early_estimates_of_influenza_vaccine_effectiveness_in_Navarre_Spain:_2012/13_mid_season_analysis_ L2 - http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20404 DB - PRIME DP - Unbound Medicine ER -